Andere talen Orient EuroPharma Co., Ltd.

Aandelen

4120

TW0004120001

slotkoers Taipei Exchange Andere beurzen 00:00:00 10-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
42,75 ^TWD	0,00%		+0,71%	+9,90%

01/03	Orient EuroPharma Co, Ltd. Rapporteert winstresultaten voor het volledige jaar eindigend op 31 december 2023	CI
2023	Orient EuroPharma Co, Ltd. Rapporteert winstresultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Regeneus Ltd announced that it expects to receive AUD 3.481164 million in funding from Zheng Yang Biomedical Technology Co., Ltd., Orient EuroPharma Co., Ltd. and other investors	05/04
Orient EuroPharma Co., Ltd. announced that it expects to receive TWD 300 million in funding	29/03
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	01/03
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11-08-23
Orient EuroPharma Co., Ltd. Appoints Jack Wang as Accounting Officer	10-08-23
Orient EuroPharma Co., Ltd. Appoints Jack Wang as Financial Officer	01-08-23
Orient EuroPharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	12-05-23
Orient EuroPharma, OncoVent Sign License Deal	30-03-23
OncoVent Enters into a License and Distribution Agreement with Orient EuroPharma for the Immunotherapeutic Candidate Oregovomab	28-03-23
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	07-03-23
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	07-03-23
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11-11-22
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	09-08-22
Orient EuroPharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	14-05-22
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25-02-22
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	11-11-21
Orient Europharma Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	12-08-21
Orient Europharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	12-05-21
Orient Europharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	25-02-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Orient EuroPharma Co., Ltd.

Aandelen

4120

TW0004120001

Andere talen

Filters